Trans 112.05(3)(b)5.5. The person has evidenced any chemical abuse or dependency within the past 2 years, that is not controlled by treatment. Trans 112.05(3)(bm)(bm) For purposes of determining eligibility for a passenger endorsement under par. (b) 1. to 3., the department shall not count violations committed prior to April 1, 1992. Trans 112.05(3)(c)(c) No person may hold any classification of operator’s license if the person is diagnosed as suffering from uncontrolled chemical abuse or dependency, as assessed by a physician, APNP or approved public treatment facility. Trans 112.05 HistoryHistory: Cr. Register, April, 1991, No. 424, eff. 5-1-91; am. (3) (b) 4., r. (3) (b) 5., Register, October, 1991, No. 430, eff. 11-1-91; emerg. cr. (3) (bm), eff. 2-20-92; cr. (3) (bm), Register, June, 1992, No. 438, eff. 7-1-92; r. (2) (b), renum. (2) (c) to (e) to be (2) (b) to (d); am. (3) (b) 4., cr. (3) (b) 5., Register, June, 1996, No. 486, eff. 7-1-96; CR 06-099: am. (2) (a) 5. and (3) (c), Register June 2007 No. 618, eff. 7-1-07. Trans 112.06Trans 112.06 Conditions affecting cardiovascular function. Trans 112.06(1)(1) With respect to conditions affecting cardiovascular function, the review boards when making recommendations, and the department when taking licensing action, may consider disorders including, but not limited to, the following: Trans 112.06(2)(2) The department may require a person to provide information on the person’s functional ability including, but not limited to, the following: Trans 112.06(2)(c)(c) Presence of pain and its frequency, location, duration and intensity. Trans 112.06(2)(e)(e) Procedures which correct a cardiovascular condition and which temporarily impair functional ability, including surgical procedures such as a coronary artery bypass graft. Trans 112.06(2)(h)(h) Results of procedures such as an electrocardiogram, stress test with thallium scan, angiography, multigated acquisition scan, echocardiogram, or electrophysiologic studies. Trans 112.06(2)(i)(i) Cardiac drug use, including rhythm control drugs, antianginal agents, cardiac glycosides, antihypertensive medication and side effects of these medications. Trans 112.06(3)(a)(a) Licensing standards. No endorsement or license may be issued to, renewed by, or held by a person who does not meet the applicable medical review standards for conditions affecting cardiovascular function of this subsection. Trans 112.06(3)(b)(b) Medical standards for school bus and passenger endorsements. A person who applies for, renews, or holds a school bus or passenger endorsement shall meet all of the following cardiovascular criteria: Trans 112.06(3)(b)1.1. The person shows no evidence of exercise-induced ischemia, arrhythmias or hypotension as evidenced by appropriate cardiac testing which has been prescribed and reviewed by a physician or APNP. Trans 112.06(3)(b)2.2. Any valvular disease is asymptomatic with no significant ventricular dysfunction. Trans 112.06(3)(b)6.6. There is no documented ventricular tachycardia, severe bradycardia, or high-grade heart block which is unable to be successfully treated. Trans 112.06(3)(b)7.7. Any cardiac incident, such as myocardial infarction, occurred more than 6 months preceding any application or renewal unless a cardiac specialist specifically recommends operation of a commercial vehicle and the person has fully recovered. Trans 112.06(3)(c)(c) Medical standards for all classes of operators licenses. A person who applies for, renews, or holds any classification of operator’s license shall meet all of the following cardiovascular function criteria: Trans 112.06(3)(c)1.1. There are no current symptoms of coronary artery disease, such as unstable angina, dyspnea, or pain at rest, which interfere with safe driving, as assessed by a physician or APNP. Trans 112.06(3)(c)2.2. There is no cause of cardiac syncope present, including ventricular tachycardia or fibrillation, which is not successfully controlled. Trans 112.06(3)(c)3.3. There is no congestive heart failure that limits functional ability and is assessed by a physician or APNP as interfering with safe driving. Trans 112.06(3)(c)5.5. There is no automatic implantable cardioverter defibrillator, unless the device is assessed by an electrophysiologist as not interfering with safe driving. Trans 112.06(3)(c)6.6. There is no valvular heart disease or malfunction of prosthetic valves that is assessed by a physician or APNP as interfering with safe driving. Trans 112.06 HistoryHistory: Cr. Register, April, 1991, No. 424, eff. 5-1-91; cr. (1) (L), (3) (b) 7., am. (3) (b) 1., r. (3) (b) 4., 5. 9., renum. (3) (b) 6. to 8. to be (3) (b) 4. to 6. and (3) (b) 10. and 11. to be (3) (b) 8. and 9., Register, June, 1996, No. 486, eff. 7-1-96; CR 04-117: r. (3) (b) 3. Register April 2005 No. 592, eff. 5-1-05; CR 06-099: am. (3) (b) 1. and (c) 1., 3. and 6., Register June 2007 No. 618, eff. 7-1-07. Trans 112.07Trans 112.07 Conditions affecting cerebrovascular function. Trans 112.07(1)(1) With respect to conditions affecting cerebrovascular function, the review boards when making recommendations, and the department when taking licensing action, may consider disorders including, but not limited to, the following: Trans 112.07(2)(2) The department may require information on a person’s functional ability including, but not limited to, the following: Trans 112.07(3)(a)(a) Licensing standards. No endorsement or license may be issued to, renewed by, or held by a person who does not meet the applicable medical review standards for conditions affecting cerebrovascular function of this subsection. Trans 112.07(3)(b)(b) Medical standards for school bus and passenger endorsements. A person who applies for, renews, or holds a school bus or passenger endorsement shall meet all of the following cerebrovascular function criteria: Trans 112.07(3)(b)1.1. Physician or APNP certifies that the person is reliable in following the person’s prescribed treatment program. Trans 112.07(3)(b)2.2. Blood pressure reading shows a systolic pressure of 180 millimeters of mercury or less and a diastolic pressure of 105 millimeters of mercury or less, with or without medication. Trans 112.07(3)(b)3.3. Any cerebrovascular incident, such as a cerebrovascular accident or endarterectomy, occurred more than 6 months ago. Trans 112.07(3)(b)4.4. There are no current residual motor deficits that interfere with safe driving. Trans 112.07(3)(b)5.5. There is no impaired reasoning or judgment, as assessed by a physician or APNP. Trans 112.07(3)(c)(c) Medical standards for all classes of operators licenses. A person who applies for, renews, or holds any classification of operator’s license shall meet all of the following cerebrovascular function criteria: Trans 112.07(3)(c)2.2. There is no impairment of reasoning or judgment preventing safe operation of a vehicle, as assessed by a physician or APNP. Trans 112.07(3)(c)3.3. There are no medications interfering with the person’s ability to operate a motor vehicle safely. Trans 112.07 HistoryHistory: Cr. Register, April, 1991, No. 424, eff. 5-1-91; am. (1) (a), (b), r. (1) (e), (3) (b) 1., (c) 3., renum. (3) (b) 2. to 6. to be (3) (b) 1. to 5. and am. 4., (3) (c) 4. to be (3) (c) 3., Register, June, 1996, No. 486, eff. 7-1-96; CR 04-117: am. (3) (b) 1. and 3. Register April 2005 No. 592, eff. 5-1-05; CR 06-099: am. (3) (b) 1. and 5. and (c) 2., Register June 2007 No. 618, eff. 7-1-07. Trans 112.08Trans 112.08 Conditions affecting endocrine function. Trans 112.08(1)(1) With respect to conditions affecting endocrine function, the review boards, when making recommendations, and the department when taking licensing action, may consider disorders including, but not limited to, the following: Trans 112.08(2)(2) The department may require information on a person’s functional ability including, but not limited to, the following:
/exec_review/admin_code/trans/112
true
administrativecode
/exec_review/admin_code/trans/112/06/3
Department of Transportation (Trans)
administrativecode/Trans 112.06(3)
administrativecode/Trans 112.06(3)
section
true
